Invention Grant
- Patent Title: Tetrazole derivatives as TRPA1 inhibitors
-
Application No.: US17356782Application Date: 2021-06-24
-
Publication No.: US11891403B2Publication Date: 2024-02-06
- Inventor: Martin Thomas Fleck , Florian Paul Christian Binder , Jens Willwacher
- Applicant: Boehringer Ingelheim International GmbH
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim International GmbH
- Current Assignee: Boehringer Ingelheim International GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent Philip I. Datlow
- Priority: EP 182987 2020.06.29
- Main IPC: C07D498/04
- IPC: C07D498/04 ; C07D471/04 ; C07D513/04

Abstract:
The present disclosure provides certain tetrazole derivatives that are inhibitors of transient receptor potential ankyrin 1 (TRPA1), and are therefore useful for the treatment of diseases treatable by inhibition of TRPA1. Also provided are pharmaceutical compositions containing the same, and processes for preparing said compounds.
Public/Granted literature
- US20210403482A1 TETRAZOLE DERIVATIVES AS TRPA1 INHIBITORS Public/Granted day:2021-12-30
Information query